, Volume 13, Issue 5, pp 459–462 | Cite as

Development of insulin resistance in normal dogs following alloxan-induced insulin deficiency

  • G. M. Reaven
  • W. S. Sageman
  • R. S. Swenson


Insulin resistance was measured in 16 normal dogs by a method involving the continuous intravenous infusion of epinephrine, propranolol, glucose and insulin. With this approach, endogenous insulin secretion is inhibited, similar steady state levels of exogenous insulin are achieved in all dogs, and the resultant steady state plasma glucose level provides a direct estimate of the ability of insulin to dispose of the infused glucose load. Thus, the higher the steady state plasma glucose level, the more the insulin resistance. Different amounts of alloxan were then administered to these dogs in order to produce insulin deficiency of varying degrees. Insulin resistance was then measured again in each dog. The results indicated that insulin resistance did not develop in dogs with only a moderate degree of insulin deficiency (fasting plasma glucose levels < 150 mg/100 ml). On the other hand, a significant degree of insulin resistance developed in dogs with severe insulin deficiency (fasting plasma glucose > 150 mg/100 ml). Furthermore, the insulin resistance that developed in dogs with severe insulin deficiency could be returned to normal with insulin replacement for one week. These results indicate that insulin resistance can occur as a secondary manifestation of insulin deficiency.

Key words

Diabetes insulin deficiency hyperglycaemia insulin resistance insulin treatment alloxan 


  1. 1.
    Reaven, G.M., Farquhar, J.W.: Steady state plasma insulin response to continuous glucose infusion in normal and diabetic subjects. Diabetes18, 273–279 (1969)PubMedGoogle Scholar
  2. 2.
    Reaven, G.M., Silvers, A., Farquhar, J.W.: Study of the relationship between plasma insulin concentration and efficiency of glucose uptake in normal and mildly diabetic subjects. Diabetes19, 571–578 (1970)PubMedGoogle Scholar
  3. 3.
    Shen, S-W, Reaven, G.M., Farquhar, J.W.: Comparison of impedance to insulin mediated glucose uptake in normal and diabetic subjects. J. Clin. Invest.49, 2151–2160 (1970)PubMedGoogle Scholar
  4. 4.
    Olefsky, J., Farquhar, J.W., Reaven, G.M.: Relationship between fasting plasma insulin level and resistance to insulinmediated glucose uptake in normal and diabetic subjects. Diabetes22, 507–513 (1973)PubMedGoogle Scholar
  5. 5.
    Ginsberg, H., Olefsky, J.M., Reaven, G.M.: Further evidence that insulin resistance exists in patients with chemical diabetes. Diabetes23, 674–678 (1974)PubMedGoogle Scholar
  6. 6.
    Ginsberg, H., Kimmerling, G., Olefsky, J.M., Reaven, G.M.: Demonstration of insulin resistance in untreated adult onset diabetic subjects with fasting hyperglycaemia. J. Clin. Invest.55, 454–461 (1975)PubMedGoogle Scholar
  7. 7.
    Reaven, G.M., Bernstein, R., Davis, B., Olefsky, J.M.: Non-ketotic diabetes mellitus: insulin deficiency or insulin resistance? Am. J. Med.60, 80–88 (1976)PubMedGoogle Scholar
  8. 8.
    Kadish, A.H., Litle, R.L., Sternberg, J.C.: A new and rapid method for the determination of glucose by measurement of rate of oxygen consumption. Clin. Chem.14, 116–131 (1968)Google Scholar
  9. 9.
    Desbuquois, B., Aurbach, G.D.: Use of polyethylene glycol to separate free and antibody bound peptide hormones in radioimmunoassays. J. Clin. Endocrinol.33, 732–738 (1971)PubMedGoogle Scholar
  10. 10.
    Pupo, A.A., Mileni, J.M., Ursich, J.M., Iamaguchi, E., Van-concellos, F.G.: Acute and late phase insulin secretion and glucose tolerance in mild alloxan diabetes in dogs. Diabetes25, 161–166 (1976)PubMedGoogle Scholar
  11. 11.
    Kimmerling, G., Javorski, C., Olefsky, J.M., Reaven, G.M.: Localization of the site(s) of insulin resistance in patients with nonketotic diabetes mellitus. Diabetes25, 673–678 (1976)PubMedGoogle Scholar
  12. 12.
    Hansen, A.P.: Normalization of growth hormone hyperresponse to exercise in juvenile diabetics after “normalization” of blood sugar. J. Clin. Invest.50, 1806–1811 (1971)PubMedGoogle Scholar
  13. 13.
    Raskin, P., Fujita, Y., Unger, R.H.: Effect of insulin-glucose infusions on plasma glucagon levels in fasting diabetics and nondiabetics. J. Clin. Invest.56, 1132–1138 (1975)PubMedGoogle Scholar
  14. 14.
    Olefsky, J.M., Reaven, G.M.: Decreased insulin binding to lymphocytes from diabetic subjects. J. Clin. Invest.54, 1323–1328 (1974)PubMedGoogle Scholar
  15. 15.
    Olefsky, J.M., Reaven, G.M.: Effects of sulfonylurea therapy on insulin binding to mononuclear leukocytes of diabetic patients. Am. J. Med.60, 89–95 (1976)PubMedGoogle Scholar
  16. 16.
    Galton, D.J., Wilson, J.P. D.: The effect of starvation and diabetes on glycolytic enzymes in human adipose tissue. Clin. Sci.41, 545–553 (1971)PubMedGoogle Scholar

Copyright information

© Springer-Verlag 1977

Authors and Affiliations

  • G. M. Reaven
    • 1
    • 2
  • W. S. Sageman
    • 1
    • 2
  • R. S. Swenson
    • 1
    • 2
  1. 1.Department of MedicineStanford University School of MedicinePalo AltoUSA
  2. 2.Veterans Administration HospitalPalo AltoUSA

Personalised recommendations